These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 33567945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.
    Uthaug MV, Lancelotta R, Szabo A, Davis AK, Riba J, Ramaekers JG.
    Psychopharmacology (Berl); 2020 Mar; 237(3):773-785. PubMed ID: 31822925
    [Abstract] [Full Text] [Related]

  • 3. Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting.
    Tagliazucchi E, Zamberlan F, Cavanna F, de la Fuente L, Romero C, Sanz Perl Y, Pallavicini C.
    Front Psychiatry; 2021 Mar; 12():720066. PubMed ID: 34803754
    [Abstract] [Full Text] [Related]

  • 4. Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
    Stenbæk DS, Madsen MK, Ozenne B, Kristiansen S, Burmester D, Erritzoe D, Knudsen GM, Fisher PM.
    J Psychopharmacol; 2021 Apr; 35(4):459-468. PubMed ID: 33501857
    [Abstract] [Full Text] [Related]

  • 5. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts.
    Graziosi M, Singh M, Nayak SM, Yaden DB.
    J Psychoactive Drugs; 2023 Apr; 55(5):558-569. PubMed ID: 37679890
    [Abstract] [Full Text] [Related]

  • 6. N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q).
    Lawrence DW, DiBattista AP, Timmermann C.
    J Psychoactive Drugs; 2024 Apr; 56(4):443-455. PubMed ID: 37428989
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
    Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R.
    PLoS One; 2019 Apr; 14(4):e0214377. PubMed ID: 31013281
    [Abstract] [Full Text] [Related]

  • 9. Neural correlates of the DMT experience assessed with multivariate EEG.
    Timmermann C, Roseman L, Schartner M, Milliere R, Williams LTJ, Erritzoe D, Muthukumaraswamy S, Ashton M, Bendrioua A, Kaur O, Turton S, Nour MM, Day CM, Leech R, Nutt DJ, Carhart-Harris RL.
    Sci Rep; 2019 Nov 19; 9(1):16324. PubMed ID: 31745107
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alterations of consciousness and mystical-type experiences after acute LSD in humans.
    Liechti ME, Dolder PC, Schmid Y.
    Psychopharmacology (Berl); 2017 May 19; 234(9-10):1499-1510. PubMed ID: 27714429
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
    Riba J, McIlhenny EH, Bouso JC, Barker SA.
    Drug Test Anal; 2015 May 19; 7(5):401-6. PubMed ID: 25069786
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulatory effects of ayahuasca on personality structure in a traditional framework.
    Netzband N, Ruffell S, Linton S, Tsang WF, Wolff T.
    Psychopharmacology (Berl); 2020 Oct 19; 237(10):3161-3171. PubMed ID: 32700023
    [Abstract] [Full Text] [Related]

  • 18. Dose-response relationships of psilocybin-induced subjective experiences in humans.
    Hirschfeld T, Schmidt TT.
    J Psychopharmacol; 2021 Apr 19; 35(4):384-397. PubMed ID: 33663259
    [Abstract] [Full Text] [Related]

  • 19. Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects.
    Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR.
    J Psychopharmacol; 2020 Sep 19; 34(9):1008-1020. PubMed ID: 32345112
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.